Objective 2.1: Continue to model and evaluate use of innovative service delivery methods to improve access to newborn screening and clinical genetic and genomic services for individuals with or at risk for heritable and metabolic disorders, and congenital malformations.
Objective 2.2: Develop and assess effective approaches for ensuring individuals who access and fully participate in newborn screening and clinical genetic and genomic services within a patient-centered medical home.
Objective 2.3: Continue to improve third-party reimbursement of genetic and genomic services including counseling, management, treatment, and testing.
Objective 2.4: Continue to develop and assess regional systems for newborn screening long-term follow-up by improving screening practices and developing, implementing, and evaluating use of evidence-based clinical guidelines.
Objective 3.1: Continue to provide leadership in the western states to facilitate public health leaders’ access to expertise in newborn screening, genetics, and genomics relevant to public health core functions.
Objective 3.2: Continue to disseminate, on a local, regional, and national level, findings from evaluation of innovations modeled in Network initiatives.
Objective 3.3: Based upon input from public health leaders and other stakeholders, create and disseminate newborn screening, genetics, and genomics educational products that may be used by public health agencies to improve knowledge and awareness of genomics within the western states population, including primary care and other healthcare providers.